Cancer medicines

Abemaciclib

Abemaciclib

A CDK4/6 inhibitor for selected breast cancers, with diarrhea needing particular attention.

Sources checked · Introductory guide

On this page

How it works

It inhibits CDK4 and CDK6, disrupting cell-cycle progression.[3]

Where it is used

Used in selected HR-positive, HER2-negative high-risk early or advanced breast cancers; combinations depend on the setting.[1]

Key safety points

Follow your team’s early diarrhea plan. Seek prompt advice for dehydration, fever, new breathlessness or leg swelling.[2]

Questions for your care team

  • What are my diarrhea medicines, contact thresholds and blood or liver test schedules?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Abemaciclib (opens in a new tab)
  2. MedlinePlus · Abemaciclib (opens in a new tab)
  3. NCI Drug Dictionary · Abemaciclib (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Abemaciclib | Cancer Encyclopedia | My Chemo Diary